The importance and significance of the largest organ of the body, i.e. skin has immensely increased in the last two decades. Increased awareness, rise in disposable income levels and the need to look more presentable in social circles along with other factors such as pollution, stress, increase in population, lack of nutrition, etc. are all paving way to manifold growth of the skincare segment, not only in India, but across the world as well.
On the other hand, due to the desire to have flawless skin and a well-contoured body, the cosmetology market has also risen likewise. Moreover, changing lifestyles and increasing demands of customers to defy aging has also led to the introduction of Artificial Intelligence (AI) in producing new products and introducing better tools for diagnoses of various skin ailments.
The urban population is getting the benefit of dermatologists and cosmetologists for their needs, whereas the rural population is more comfortable with the OTC (Over the Counter) products, hence having an increased demand for cost-effective home treatments. This overall need of the market has made the Research & Development department to work overtime for products which are cost-effective, therapeutically potent with less downtime.
Dermascopy is rapidly evolving as an intelligent dermatology software tool to support clinical decisions.
It is a tool which conducts complete body photography to detect moles all over the body.
Another advanced tool in the field of dermatology is 3D Body Mapping which is an emerging as an effective tool to manage patients. In a recent discovery,Vitamin D deficiency is linked to acne and infant eczemas were linked to food allergy. Lasers, biologics and targeted therapies are the great advancements in dermatology.
Cosmetology is mainly associated with correction, elegant, radiant and flawless skin, which has more to do with grooming aesthetic looks. With the increase in disposable income levels among the youth, this segment has grown dramatically,which in turn added to the robust growth in dermatology as a whole.
In this regard, India is no exception,mainly in skincare, hair care, make-up and body sculpting. Men started sharing their part of the story in this regard; the taboo of beauty no longer remains gender-specific with many products specifically crafted for men that are available in international and OTC markets.
A lot of MNCs came out with products exclusively for men. Many companies have set a benchmark in dermatology such as Allergen, Galderma, Valeant, Sanofi Aventis,GSK,Glenmark,etc.
It is important to understand that a dermatologist should not be considered as a 'last resort' when it comes to treating skin-related ailments. A dermatologist does not just treat skin ailments, but they also help treat hair and nail-related problems. They also perform different surgeries for the same.
A dermatologist not only treats the infective causes but also helps us look attractive. Dermatologists play an important role in treating the demands of all age groups and understand the degenerative process of the skin much better than anyone else. With the help of proper techniques, the degenerative process of the skin can be delayed, hence giving the person a more youthful look.
Dermatologists are just using the knowledge with a scientific background, something which our ancestors have been doing for centuries, though unknowingly. Beautification is as old as 5000 years and its practices and techniques have only evolved over time.
Kanak Godbole, a law student, was exhausted with the full-stop her life had reached to. From the first week of Apr.'20 it seemed like everything has stuck in a time warp and she wanted to break free. That is when the first COVID case in her apartment turned up. The municipal agencies came with their chemical sprays and the whole premises were left in a sticky mess.
Well, all of those safety measures stopped at her doorstep and that made Kanak think. What if a machine is available that will sanitize everything without leaving any mess behind and can be used both, inside the house as well as in the premises? What if the same machine can also be used in offices, lobbies, vehicles and lifts? People can then actually get back to work, and then come back home to sure- safe conditions and in this way, the fear of the virus will be gone!
Kanak's wish-list further went multifold. She being a strong believer of making India “Atma-Nirbhar”, she wished to have a sanitizing machine which will be completely made in India. She also wished to make this disinfecting machine available at an affordable price.
As well as this being a daydream, it was also an idea which Kanak decided to act upon. And it was then when GermACE was born. And so with the help of her father, Mr. Jitendra Godbole, the work began. From being just a passing thought to getting into the actual design and production and now into the market, the journey had been nothing that Kanak had ever expected.
“Manufacturing a completely new product during lockdown was extremely difficult. When our product was about to launch, our certifying authority (ICT) came up with very valuable additions in the product. Once again our team was caught up in the R&D - to - prototyping cycle. Our product launch was delayed by 40 days. However, we did not give up. With technical assistance of ICT, we could finally launch a near to perfect product, which can match international standards.” said a beaming Kanak as she took us through the journey.
Kanak had roped in the services of the design firm SynchronTec, to achieve operational excellence. The members of the GTWOTech team, Jitendra Godbole, Omkar Thakur, Kunal Godambe and Anvay Kadulkar are all engineers with more than 50 years of combined experience in varied fields.
“It was a seamless amalgamation of ideas and ideologies. Use of right kind of UV-C Germicidal tubes, research, analysis, design and value chain are the prime factors of our success.” said Jitendra Godbole as he explained how the manufacturing went on cradling back and forth as quality standards, functionalities and aesthetics clashed with each other. But then all of them had the same goal – bring the best and the safest product in the market. “Make in India” and “Think Local Go Global” are their team mantras.
GermACE has three UV- Disinfection products in the market, each one designed to mitigate the risk from each of the three mediums of the spread of Corona Virus. UV Room Sanitizer disinfects surfaces of all the objects in the radius of 15 feet targeting the first medium – touch. UV AeroSan disinfects air and recirculates sterilized air targeting the next medium – air. The UV Sanitizer Case disinfects personal & handheld objects like mobile phones, wallet, purse, files etc. including vegetables and groceries.
Dr. Sujata Kiran Vaidya is the Director of Supra Health Solutions LLP, which was formerly known as Health Solutions. Dr. Vaidya's detailed bio is just a short summary of the numerous and ground-breaking achievements she has done in her life. She has spoken extensively about the importance of including the mental aspect in the concept of well-being at a day and time when people didn't give much importance to mental health as much as they stressed on the physical aspect of 'well-being'. Here is a detailed story on the life journey in the world of Healthcare of Dr. Sujata Vaidya.
Dr. Vaidya completed her schooling from Kendriya Vidyalaya in North India with other children of the Armed Forces where she led an army life and learned the basics of humanity, which early on, taught her to never discriminate between classes and creeds and gave a lot of stress to the importance of maintaining close bonds with friends and family. On a lighter note,Dr. Vaidya was heavily involved in the world of sports and other outdoor activities in her school days and didn't show much interest in being a 'straight - A' student.
She eventually completed her B.Sc. degree and also grabbed a scholarship from Fergusson College, Pune and also completed her MBA degree from one of the most renowned colleges in India,PUMBA.
She began her career in the year 1980 by working part-time during her college days. She has come a long way as she is the owner of her own clinic called Health Solutions (now called Supra Health Solutions). She has also successfully managed her own advertising company in Pune from 1987 to 97. This advert company was amongst the very few in Pune which was run by women, and that too was into Industrial Advertising. The nature of the work demanded a lot of technical work, shop floor photo shoots and international conferences.
She then shifted to Singapore 1997 to be with her family and then went to the UK. She came back to India from Singapore in 1999 and became in-charge of Centre for Biofield Sciences as a Coordinator and then later held the reigns of the institute as a Director. She eventually started her own practice in Integrative Therapeutics (Holistic medicine and AURA Scanning) after securing a PhD in Biofield Sciences. She is currently the coordinator and mentor at the Institute of Integrative Healthcare (IIHc).
She received guidance from some of the best experts in the field of Science and Medicine. They were the ones who nurtured the spirit of Research, Spirituality and Integrative life in Dr. Vaidya. Padmabhushan awardee Dr. Vijay Bhatkar,Chancellor of Nalanda University, and a pioneer of CDAC was one of Dr. Vaidya's guides and mentors. He is also the initiator of India's first supercomputer Param. He is fondly called 'Spiritual Scientist'.
Another mentor who is said to have had a deep impact on Dr. Vaidya's life and Professor Dr B M Hegde, a renowned Cardiologist and Vice Chancellor of Manipal University, Co-Chairman of the TAG-VHS Diabetes Research Centre, Chennai and the chairman of Bharatiya Vidya Bhavan. He is the one who instilled deep respect for Ayurveda,Natural sciences and Healing in Dr. Vaidya.
Such is the close bond shared between Dr. Vaidya and Dr Hegde that,the latter has also written the Foreword for her book “Heart and Health like Never Before” and Dr Bhatkar's organisation, India International Multiversity published her book with his back cover comment. She then went on to become the Director of the Institute of Integrative Healthcare (IIHc), an initiative of Multiversity under the Mentorship of Dr Bhatkar in 2008.
The main thing that sets Supra Health Solutions LLP apart is that it is amongst the first to take on treatment of COVID patients under a Registered Clinical Trial as a joint venture between SKNMC and IIHc to beat the 2020 pandemic.
Health Solutions has also won various awards for its flagship products, services and results such as the India Pharma Award 2017. And they also got the opportunity to give a presentation in the Indian Science Congress,2017.
Dr. Vaidya did not have it easy when she first entered the world of medicine and healthcare. She says that the medical community has created its own hurdles to stop her from succeeding in a man's world, as healthcare is a male-dominated sector.
And another great challenge that she had to face was being a frontrunner in the field of medicine,without a medical degree,which is not a common sight in the world of Healthcare. However, she crossed all of these hurdles with utter grit and determination and she feels that she couldn't have made it had it not been for the support of her patients, students and her teachers.
Dr. Vaidya believes in keeping an 'all-inclusive' work culture that helps her grow in a positive way, both as a person and as a professional. She puts special emphasis on learning from the respondents, be it the patients, students or markets as they can give some of the best lessons of both personal and professional lives.
She has stressed on the importance of being grateful for what one has as this world is a beautiful place and she feels truly grateful for what she has in her life,both on the personal and professional fronts. She always advises people to never stop asking questions as there is so much more to learn from everyone and everything.
According to Dr. Vaidya, it is vital to be passionate in life. She believes in doing what one loves doing and this passion and love for one's work will reap far more rewards in life. It is also very important to inculcate commitment as a life principle as people appreciate commitment. She says that it need not mean one has to be the best; but it is very important to always put in the best of efforts in everything one does.
Dame Emma Walmsley is the chief executive officer (CEO) of GlaxoSmithKline. She succeeded Sir Andrew Witty,who retired in March 2017. Before GSK, she worked for L'Oréal for 17 years, and was a non-executive director of Diageo until September 2016. She grew up Barrow-in-Furness,Cumbria. She was born in the month of June, 1969.
Walmsley was born in Barrow-in-Furness in Lancashire (now Cumbria), the daughter of Vice-Admiral Sir Robert Walmsley and Lady (Christina) Walmsley (born Christina V Melvill). She boarded at St Swithun's School,Winchester, and has an MA in Classics and Modern Languages from Oxford University.
Walmsley worked at ''Loréal for 17 years where she held a variety of general management and marketing roles in Paris, London and New York. From 2007 she was based in Shanghai as General Manager, Consumer Products for L'Oreal China, where she ran the company's Chinese consumer products business, overseeing global brands including L'Oréal Paris,Maybelline and Garnier,as well as Mininurse,a Chinese skincare brand. At the time of her move to GSK in 2010, Advertising Age quoted company insiders surprised at her departure from L'Oreal, where she had been tipped for a senior global management role.
She joined GlaxoSmithKline in May 2010 as President of Consumer Healthcare Europe, rising in October 2011 to head its global consumer healthcare division as President of Consumer Healthcare Worldwide and a member of the executive team. In March 2015 she became the Chief Executive Officer of Consumer Healthcare.
Walmsley was particularly involved in leading the company's sales drive in emerging markets. Under her leadership the consumer products division, one of the world's largest consumer health groups with brands including Panadol,Voltaren and Horlicks,made up nearly a quarter of GlaxoSmithKline's revenues.
She took over as CEO of the company in April 2017,making her the first woman to run a major pharmaceutical company. At the time, analysts commented that Walmsley's appointment could be seen as a signal that GSK would keep its consumer operation as a core part of its business.
In August 2017,Walmsley stated that her priority was for GlaxoSmithKline to become more adept at developing and commercialising new drugs. She announced a narrowed set of priorities for drug development, setting a target of allocating 80% of pharma R&D capital to a maximum of four disease areas. However,industry analysts noted that GlaxoSmithKline's decisions to hold its dividend would restrict the amount of cash available for R&D and acquiring intellectual property from other companies. Walmsley has made much-needed changes, her most important move was "the transformation of the leadership team within R&D."